KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
EBITDAProfit After TaxShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

QuidelOrtho (QDEL) EPS (Weighted Average and Diluted) (2021 - 2024)

QuidelOrtho's EPS (Weighted Average and Diluted) history spans 3 years, with the latest figure at -$9.71 for Q4 2023.

  • For Q4 2023, EPS (Weighted Average and Diluted) fell 510.42% year-over-year to -$9.71; the TTM value through Dec 2023 reached -$9.5, down 501.55%, while the annual FY2024 figure was -$30.54, 20260.0% down from the prior year.
  • EPS (Weighted Average and Diluted) for Q4 2023 was -$9.71 at QuidelOrtho, down from -$0.23 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $11.31 in Q2 2022 and bottomed at -$9.71 in Q4 2023.
  • The 3-year median for EPS (Weighted Average and Diluted) is $0.4 (2021), against an average of $0.98.
  • The largest annual shift saw EPS (Weighted Average and Diluted) decreased 20.0% in 2022 before it tumbled 510.42% in 2023.
  • A 3-year view of EPS (Weighted Average and Diluted) shows it stood at $5.08 in 2021, then crashed by 94.49% to $0.28 in 2022, then plummeted by 3567.86% to -$9.71 in 2023.
  • Per Business Quant, the three most recent readings for QDEL's EPS (Weighted Average and Diluted) are -$9.71 (Q4 2023), -$0.23 (Q4 2023), and -$0.8 (Q3 2023).